Magnesium Sulfate Torbay Pharmaceuticals

Magnesium sulfate, the active ingredient in Magnesium Sulfate Torbay Pharmaceuticals, is an electrolyte presented as a solution for injection for intramuscular and intravenous use. It is employed to prevent and treat eclampsia and pre‑eclampsia, correct severe hypomagnesemia, and manage torsades de pointes and acute severe asthma.

GNH USA supplies Magnesium Sulfate Torbay Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is an electrolyte replacement that acts on calcium antagonism and neuromuscular excitability.

- Pre‑eclampsia/eclampsia: prevents seizures and stabilises maternal blood pressure. - Severe hypomagnesemia: restores normal serum magnesium concentrations. - Torsades de pointes: terminates ventricular tachyarrhythmia by stabilising cardiac membranes. - Acute severe asthma: provides bronchodilation as an adjunct to standard therapy.

Magnesium sulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Flushing or warmth at the injection site - Sweating or feeling hot - Nausea or vomiting - Headache - Hypotension - Dizziness

Serious or Rare Side Effects: - Respiratory depression or arrest - Severe hypotension leading to shock - Cardiac arrhythmias or cardiac arrest - Hypermagnesemia with muscle weakness or paralysis - Neuromuscular blockade - Anaphylactic reactions

Magnesium sulfate requires careful assessment before administration.

- Renal impairment: monitor serum magnesium and adjust dose. - Cardiac disease: avoid rapid infusion in patients with conduction abnormalities. - Neuromuscular disorders: use with caution in myasthenia gravis or spinal cord injury. - Concomitant calcium channel blockers: increased risk of hypotension and bradycardia. - Serum monitoring: check magnesium levels regularly during prolonged therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Calcium channel blockers: additive hypotensive effect. - Neuromuscular blocking agents: prolonged paralysis. - Aminoglycoside antibiotics: enhanced neurotoxicity. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor blood pressure and renal function. - β‑agonists used in asthma: possible reduced bronchodilator response. - Loop diuretics: may increase magnesium loss, requiring dose adjustment.